Events

Back to Events list

7th Annual Patent Law Institute

03/18/2013

The Institute is designed to be of ultimate practice value to all three subgroups in the patent law community: patent prosecutors, patent litigators, and strategic/transactional lawyers. The two-day schedule includes seven plenary sessions of interest to all patent lawyers and five breakout sessions in each of the three subgroups. You design the two-day schedule that best meets your professional needs. Do not miss this unique opportunity to sharpen your practice skills and network with federal judges, USPTO officials, in-house counsel and outside patent lawyers.

As part of the Litigation breakout sessions, Asim Bhansali will present "Developments in Pharma and Biotech Patent Litigation." This session will cover:

  • AIA one year and counting – has it impacted pharma and biotech litigation?
  • The continuing drama around reverse payment pharma settlements
  • The evolving FDA guidance and rules for follow-on biologics
  • The role of Section 101 challenges in pharma and biotech litigation

For a complete program agenda, please click here.

About Asim Bhansali
Mr. Bhansali has extensive trial and litigation experience in antitrust, intellectual property, and complex commercial matters. His antitrust cases span a range of high-technology, financial, and life-science industries, and have included several of the largest private civil actions in U.S. history. Mr. Bhansali has defended clients in consumer class actions, including alleged violations of California unfair competition laws. His intellectual property cases have included patent and trade-secret actions in the pharmaceutical, computer-software, internet, and semiconductor industries.

Mr. Bhansali is a frequent contributor to legal publications and conferences in antitrust and intellectual property, and has participated in and chaired programs on these areas for the Practicing Law Institute. He also serves on the Executive Committee of the California State Bar’s Antitrust and Unfair Competition Section.